Troluce Capital Advisors LLC

Position in STOK — Stoke Therapeutics, Inc.

CIK 1910321 DORADO, PR

Position in STOK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$16,242,731

-$5,012,437 QoQ

Shares Held

496,416

-24.0% QoQ

Ownership

0.769%

of shares outstanding

% of Portfolio

6.08%

of 13F equity value

Holder Rank

#29

of 196 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Troluce Capital Advisors LLC holds $63,017,746 across 3 Biotechnology names. STOK ranks #2 (25.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MLYS	Mineralys Therapeutics, Inc.	1,728,753	$46,641,755
2	STOK	Stoke Therapeutics, Inc. This page	496,416	$16,242,731
3	ABVX	Abivax S.A.	1,000	$133,260

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,242,731	496,416	-24.0%	Shares	Sole	2026-08-14
2026-03-31	$21,255,168	652,800	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.